|
[1]Liu M, Kong XX, Yang P, et al.Effect of fibroblast growthfactor-21 on lipid metabolism of nonalcoholic fatty liver dis-ease cell model induced in vitro[J].J Jilin Univ (Med Edit) , 2012, 38 (3) :477-481. (in Chinese) 刘敏, 孔祥鑫, 杨苹, 等.成纤维细胞生长因子-21对体外诱导的非酒精性脂肪肝细胞模型脂代谢的影响[J].吉林大学学报 (医学版) , 2012, 38 (3) :477-481.
|
|
[2]Chalasani N, Younossi Z, Lavine JE, et al.The diagnosis andmanagement of non-alcoholic fatty liver disease:practiceguideline by the American Association for the Study of LiverDiseases, American College of Gastroenterology, and the A-merican Gastroenterological Association[J].Hepatology, 2012, 55 (6) :2005-2023.
|
|
[3]Raszeja-Wyszomirska J, Lawniczak M, Marlicz W, et al.Non-alcoholic fatty liver disease-new view[J].PolMerkur Lekarski, 2008, 24 (144) :568-571.
|
|
[4]Liu CH, Liu P, Hu YY, et al.Progress of clinical and basic re-search on liver fibrosis with traditional chinese medicine[J].World Sci Technol-Mod Traditi Chin Med, 2007, 9 (2) :112-119. (in Chinese) 刘成海, 刘平, 胡义扬, 等.中医药抗肝纤维化临床与基础研究进展[J].世界科学技术-中医药现代化, 2007, 9 (2) :112-119.
|
|
[5]Nan YM.Advance in pathogenesis of non-alcoholic fatty liv-er disease[J].Mod Digest Inervent, 2009, 14 (3) :169-172. (in Chinese) 南月敏.非酒精性脂肪性肝病发病机制的研究进展[J].现代消化及介入诊疗, 2009, 14 (3) :169-172.
|
|
[6]Jiao XF, Jiang SS, Han YM.Progress of tradition Chinesemedicine and pharmacy on nonalcoholic fatty liver diseases[J].Hunan J Traditi Chin Med, 2007, 23 (1) :86-88. (inChinese) 焦希斐, 蒋士生, 韩育明.非酒精性脂肪性肝病的中医药研究进展[J].湖南中医杂志, 2007, 23 (1) :86-88.
|
|
[7]Liu P, Wu DZ, Liu CH, et al.Mechanism study on combina-tion of chinese herbal formula to support anti-pathogenic a-bility and dissipate blood stasis in promoting reversion of liverfibrosis in CCI4 rats[J].Acta Univ Traditi Med Sin Pharma-col Shanghai, 2002, 16 (1) :37-41. (in Chinese) 刘平, 吴定中, 刘成海, 等.扶正化瘀中药复方促进CCl4大鼠肝纤维化逆转的配伍机理研究[J].上海中医药大学学报, 2002, 16 (1) :37-41.
|
|
[8]Jia YH, Wang RQ, Mi HM, et al.Fuzheng Huayu recipe pre-vents nutritional fibrosing steatohepatitis in mice[J].LipidsHealth Dis, 2012, 11 (1) :45.
|
|
[9]Wang QL, Tao YY, Shen L, et al.Chinese herbal medicineFuzheng Huayu recipe inhibits liver fibrosis by mediating thetransforming growth factor-β1/Smads signaling pathway[J].J Chin Integr Med, 2012, 10 (5) :561-568. (in Chi-nese) .王清兰, 陶艳艳, 沈丽, 等.扶正化瘀方影响转化生长因子β1/Smad信号通路的抗肝纤维化作用机制[J].中西医结合学报, 2012, 10 (5) :561-568.
|
|
[10]Liu C, Jiang CM, Liu CH, et al.Effect of Fuzhenghuayu de-coction on vascular endothelial growth factor secretion in he-patic stellate cells[J].Hepatobiliary Pancreat Dis Int, 2002, 1 (2) :207-210.
|
|
[11]Kon K, Ikejima K, Hirose M, et al.Pioglitazone prevents ear-ly phase hepatic fibrogenesis caused by carbon retrachloride[J].Biochem Res Commun, 2002, 29 (1) :55-61.
|
|
[12]Nan Y, Wang R, Zhao S, et al.Heme oxygenase-1 pre-vents non-alcoholic steatohepatitis through suppressinghepatocyte apoptosis in mice[J].Lipids Health Dis, 2010, 9:124.
|
|
[13]Wang RQ, Nan YM, Wu WJ, et al.Induction of heme oxy-genase-1 protects against nutritional fibrosing steatohepati-tis in mice[J].Lipids Health Dis, 2011, 10:31.
|
|
[14]Wu XL, Zeng WZ, Jiang MD, et al.Research progress insignal transduction pathway of liver fibrosis[J].World ChinJ Dig, 2006, 14 (22) :2223-2228. (in Chinese) 吴晓玲, 曾维政, 蒋明德, 等.肝纤维化的信号转导通路[J].世界华人消化杂志, 2006, 14 (22) :2223-2228.
|
|
[15]Friedman SL.Hepatic stellate cells:protean, multifunction-al, and enigmatic cells of the liver[J].Physiol Rev, 2008, 88 (1) :125-172.
|
|
[16]An DM, Ji G, Xing LJ, et al.Relationship between uroki-nase plasminogen activator and liver cirrhosis[J].WorldChin J Dig, 2006, 14 (21) :2106-2111. (in Chinese) 安德明, 季光, 邢练军, 等.uPA纤溶途径与肝纤维化[J].世界华人消化杂志, 2006, 14 (21) :2106-2111.
|
|
[17]Liu CH, Liu P, Hu YY, et al.Effects of salvianolic acid-A onrat hepatic stellate cell proliferation and collagen production inculture[J].Acta Pharmacol Sin, 2000, 21 (8) :721-726.
|
|
[18]Liu P, Liu CH, Wang HN, et al.Effect of salvianolic acid Bon collagen production and mitogen-activated protein kinaseactivity in rat hepatic stellate cells[J].Acta Pharmacol Sin, 2002, 23 (8) :733-738.
|
|
[19]Ji G, Wang L, Zhang SH, et al.Effect of chinese medicineQinggan Huoxuefang on inducing HSC apoptosis in alcoholicliver fibrosis rats[J].World J Gastroenterol, 2006, 12 (13) :2047-2052.
|
|
[20]Guo SG, Zhang W, Jiang T, et al.Influnence of serum col-lected from rat perfused with compound Biejiaruangan drugon hepatic stellate cells[J].World J Gastroenterol, 2004, 10 (10) :1487-1494.
|
|
[21]Yao L, Yao ZM, Weng H, et al.Effect of rat serum contai-ning Biejiajian oral liquid on proliferation of rat hepatic stellatecells[J].World J Gastroenterol, 2004, 10 (13) :1911-1913.
|
|
[22]Shen B, Yu J, Wang S, et al.Phyllanthus urinaria amelio-rates the severity of nutritional steatohepatitis both In vitroand in vivo[J].Hepatology, 2008, 47 (2) :473-483.
|
|
[23]Lian J, Lv ZS, Wang XL.Study on the prevention of nonal-coholic steatohepatitis with fibrosis by Ruangan compound[J].Chin J Integra Tradit West Med Liver Dis, 2008, 18 (3) :164-166. (in Chinese) 连佳, 吕宗舜, 王绪林.软肝煎对非酒精性脂肪肝大鼠肝纤维化的预防作用[J].中西医结合肝病杂志, 2008, 18 (3) :164-166.
|
|
[24]Shen L, Dou AX, Pan H, et al.Experimental study of treat-ment of nonalcoholic fatty liver disease with chitosan in rats[J].Chin Hepatol, 2009, 14 (1) :20-22. (in Chinese) 沈镭, 窦爱霞, 潘浩, 等.壳聚糖治疗大鼠非酒精性脂肪性肝病的初步试验研究[J].肝脏, 2009, 14 (1) :20-22.
|
|
[25]Lou SY, Liu Y, Ma YY, et al.Effects of Yiqi Sanju Formulaon non-alcoholic fatty liver disease:a randomized controlledtrial[J].J Chin Integr Med, 2008, 6 (8) :793-798. (inChinese) 娄少颖, 刘毅, 马宇滢, 等.益气散聚方治疗非酒精性脂肪性肝病随机对照临床试验[J].中西医结合学报, 2008, 6 (8) :793-798.
|
|
[26] Gu S, Huang MX.Clinical observation of Qianggan capsule inthe treatment of non-alcoholic fatty liver fibrosis[J].ChinJ Hepatol, 2011, 19 (10) :791-792. (in Chinese) 古赛, 黄秒兴.强肝胶囊治疗非酒精性脂肪性肝纤维化的疗效[J].中华肝脏病杂志, 2011, 19 (10) :791-792.
|
|
[27]Liu P, Mu YP, Liu CH.Clinical and basic progress of tradi-tional Chinese medicine in chronic liver disease[J].J ClinHepatol, 2011, 27 (5) :451-457. (in Chinese) 刘平, 慕永平, 刘成海.中医治疗慢性肝病的临床与基础研究进展[J].临床肝胆病杂志, 2011, 27 (5) :451-457.
|
DownLoad: